جستجوی استاد راهنمای دانشگاهی

Rosario Gil García is a Professor in the Department of Genetics at the Faculty of Biological Sciences, University of Valencia. She is affiliated with the Institute for Biological Systems Integration (I2SYSBIO) and leads research within the GENEVOL Evolutionary Genetics group. Her work bridges molecular genetics, evolutionary biology, and systems biology. Her research focuses on evolutionary genetics of microbial symbioses , particularly in insects. Key areas include genome reduction, minimal genomes, endosymbiont evolution (e.g., Buchnera , Tremblaya , Wolbachia ), and the functional dynamics of gut microbiota in cockroaches and aphids. She investigates how long-term symbiosis shapes genome architecture and metabolic dependencies. The recent publication trends highlight a strong emphasis on minimal cellular systems , synthetic biology applications , and vector control strategies using Wolbachia-mediated incompatibility in Aedes albopictus . Her work combines comparative genomics, experimental microbiology, and systems-level modeling to understand the limits of life and harness symbiosis for biotechnological innovation. Scientific Awards: No awards explicitly mentioned in the provided text. Advising and Grants: While no list of advisees is provided, her role as a PhD supervisor (having been supervised herself) and her leadership in a major research group suggest active mentoring. She is likely involved in competitive research grants related to evolutionary genomics and synthetic biology, though specific funding sources are not listed. Labs and Teams: She is an integral member of the GENEVOL Evolutionary Genetics research group and the I2SYSBIO institute, both of which foster interdisciplinary research in biological systems, evolution, and genomics. These affiliations provide a collaborative environment for advanced genomic and experimental studies.

• Evolutionary Genetics
• Microbial Symbiosis
• Genome Reduction
• +۷ مورد دیگر

Fernando Gonzalez Candelas is a Professor in the Department of Genetics at the Faculty of Biological Sciences, Universitat de València, Spain. He leads the EVOSALUD research group (Evolution and Health: Experimental evolution and epidemiology), hosted within the Institute for Biological Systems Integration (I2SYSBIO). His work bridges evolutionary biology, genomics, and public health, focusing on microbial pathogens and their transmission dynamics. His research interests lie at the intersection of evolutionary genetics , genomic epidemiology , and infectious disease dynamics . He investigates the genetic basis of virulence, antimicrobial resistance, and host adaptation in pathogens such as SARS-CoV-2, Treponema pallidum , Klebsiella pneumoniae , and Candida auris . His group applies high-throughput sequencing, phylogenetics, and bioinformatics to understand short- and long-term pathogen evolution. The recent publications highlight a strong focus on real-time genomic surveillance of emerging pathogens, particularly during the COVID-19 pandemic. His work spans from technical improvements in sequencing and analysis (e.g., deletion repair, genotyping discrepancies) to large-scale epidemiological inference (e.g., transmission patterns, recombination, resistance evolution). A recurring theme is the use of both modern and ancient genomes to reconstruct the evolutionary history of pathogens. His scientific contributions are recognized through active participation in national and international research consortia such as RELECOV and SeqCOVID-Spain. He has contributed significantly to understanding the first wave of the pandemic in Spain and the evolution of SARS-CoV-2 variants. He earned his PhD from the Universitat de València in 1988 with a thesis on larval competition in Drosophila , indicating a long-standing interest in evolutionary processes. While no formal awards are listed in the provided text, his leadership in high-impact research and sustained publication record suggest significant recognition in his field. Fernando Gonzalez Candelas advises students and leads a research team focused on pathogen genomics. His lab, EVOSALUD, is actively involved in projects related to wastewater monitoring, nosocomial outbreaks, and the development of tools like VIPERA for viral intra-patient evolution analysis. The group’s work has direct implications for public health policy and clinical microbiology.

• Evolutionary Genetics
• Microbial Genomics
• Genomic Epidemiology
• +۷ مورد دیگر

Martin Aigner is Associate Professor and Private Lecturer at the Karl Landsteiner Private University of Health Sciences, where he heads the Clinical Department of Psychiatry and Psychotherapeutic Medicine at Tulln University Hospital. He also teaches at the Medical University of Vienna and the University for Continuing Education Krems. A board member and president (2022–2025) of the Austrian Society for Psychiatry, Psychotherapy, and Psychosomatics (ÖGPP), he is also involved in the Austrian Pain Society and Austrian Balint Society. His research interests center on the integration of biological, psychological, and social factors in psychiatry, with key areas including transitional psychiatry, obsessive-compulsive and mood disorders, the gut-brain axis, and the impact of environmental toxins like mycotoxins on mental health. He leads the PhD program in 'Mental Health and Neuroscience' and supervises doctoral research. His recent publications reflect a strong trend in interdisciplinary mental health research, combining clinical psychiatry with neuroscience, nutrition, and digital health. Themes include neurofeedback for addiction, microbiome influences on depression, and psychosomatic manifestations in chronic conditions. His work often involves neuroimaging and clinical trials. Three scientific prizes from the Austrian Pain Society Scientific prize from the Vienna Association for Neurology and Psychiatry Contributor to WFSBP guidelines on pharmacological treatment of eating disorders Co-author of guidelines for post-viral conditions He serves as principal investigator in multiple funded projects, including studies on depression and the microbiome, probiotics, and psychosis triggers. He is also co-investigator in follow-up care and community mental health initiatives. Aigner is editor-in-chief of psychopraxis. neuropraxis and advocates for digital health literacy and sustainable mental health structures, particularly in youth care. He leads the Research Center for Transitions Psychiatry, emphasizing early intervention, resilience, and patient empowerment through recovery companions. His team includes habilitated senior physicians, fostering innovation in clinical and research settings.

• Psychiatry
• Neurology
• Psychotherapeutic Medicine
• +۱۲ مورد دیگر

Adam Kleczkowski is a Professor in the Department of Mathematics and Statistics at the University of Strathclyde, where he holds the Global Talent Chair. He is actively involved in research, supervising PhD students, and contributing to public health policy, particularly in epidemiological modeling. University: University of Strathclyde School: Faculty of Science Department: Department of Mathematics and Statistics Position: Professor Email: a.kleczkowski@strath.ac.uk ORCID: 0000-0003-1384-4352 Twitter: @aklecz Education: Doctor of Science in Theoretical Physics, Jagiellonian University (1989) Master of Physics, Jagiellonian University (1984) Adam Kleczkowski's research focuses on mathematical biology, particularly in modeling infectious diseases in human, animal, and plant populations. His work integrates ecological modeling, bioeconomic analysis, and public health, with applications in food security, sustainability in aquaculture, and pollination services. He specializes in parameter estimation for epidemiological systems and develops models to inform disease control strategies. His recent contributions include modeling the spread of COVID-19 in Scottish care homes and analyzing the risks of measles outbreaks due to declining vaccination rates. His recent publications and blog posts reflect a strong trend in combining rigorous mathematical modeling with accessible science communication. He frequently writes for The Conversation and maintains two blogs—'Statistically (in)significant' in English and 'Pandemia 2021' in Polish—covering topics such as tuberculosis, immigration, aging populations, and election data. His scientific work is supported by major funders including NERC, MRC, BBSRC, Scottish Government, and Defra. Scientific Contributions and Outreach: Member, Science Advice and Response Team, Plant Health Centre (Scotland) Expert contributor to Scottish Government on Plant Health business case Contributor to Scottish Government and Public Health Scotland COVID-19 modeling Author of 14 articles in The Conversation (over 1.5 million reads) Regular science blogger and tweeter (@aklecz) He has led or participated in 24 research projects, including international collaborations such as a Memorandum of Understanding with ICRISAT. He has supervised multiple research students and projects, and his work contributes to UN Sustainable Development Goals related to health, food security, and sustainable agriculture. He is also an Honorary Professor at the University of Stirling (2018–2020), reflecting his ongoing academic influence.

• Mathematical Biology
• Epidemiology
• Ecological Modeling
• +۱۲ مورد دیگر

Lisa Gale Suter, M.D. is a Professor of Medicine in the Section of Rheumatology, Department of Internal Medicine at Yale University School of Medicine. She serves as Senior Director of Quality Measurement Programs at the Center for Outcomes Research & Evaluation (CORE), where she leads major federal contracts with the Centers for Medicare & Medicaid Services (CMS) on hospital and clinician performance measures. She is also co-chair of the Quality Measures Subcommittee of the American College of Rheumatology’s Quality of Care Committee, overseeing national measure development. Professor, Section of Rheumatology, Department of Internal Medicine, Yale School of Medicine Senior Director, Quality Measurement Program, Center for Outcomes Research & Evaluation (CORE) Co-Chair, Quality Measures Subcommittee, American College of Rheumatology Dr. Suter’s research centers on quality measurement, healthcare outcomes, and technology assessment in rheumatology and musculoskeletal diseases . She has led or consulted on over 33 hospital-level outcome measures, with many implemented in federal payment programs. Her work emphasizes patient-reported outcomes, risk adjustment, and performance evaluation in complex healthcare systems. Her recent publications reveal a strong trend in hospital quality metrics, data validation in Medicare Advantage, patient-reported outcomes in lupus, and infection screening in biologic therapy . She frequently collaborates with leading health services researchers at Yale, such as Harlan Krumholz and Arjun Venkatesh, and contributes to high-impact journals including JAMA Network Open , Health Services Research , and Arthritis Care & Research . Dr. Suter has received significant recognition for her contributions to arthritis research: Named One of Most Important OA Imaging Publications in 2009 (World Congress on Osteoarthritis) Named Top Ten Advance in Arthritis Research for 2009 (Arthritis Foundation) She continues to advise on national quality initiatives and lead interdisciplinary research teams focused on improving rheumatology care delivery and healthcare system performance. Her leadership in both academic medicine and national policy underscores her role as a key figure in advancing evidence-based, patient-centered care.

• Rheumatology
• Quality Measurement
• Healthcare Outcomes
• +۷ مورد دیگر

Professor Jo Leonardi-Bee is a faculty member at the University of Nottingham within the School of Medicine . As Professor of Evidence Synthesis and Co-Director of the Nottingham Centre for Evidence-Based Healthcare (JBI Centre of Excellence), her work focuses on quantitative evidence synthesis, Cochrane reviews, and clinical guideline development. Education: BSc in Mathematics & Chemistry, Nottingham Trent University MSc in Medical Statistics, University of Leicester PhD and PGCHE, University of Nottingham Her research spans tobacco control (smoking cessation, legislation impact, maternal exposure) and dermatology (skin cancer, corticosteroid safety). She specializes in meta-analysis techniques, systematic reviews, and health policy evaluation, with over 50 peer-reviewed publications. Recent publications highlight trends in respiratory health (alcohol/smoking effects), pregnancy outcomes (smoking cessation interventions), and allergy prevention (infant dietary guidelines). She serves as Statistical Editor for the British Journal of Dermatology and former Cochrane Skin Group editor. Teaching includes postgraduate modules in systematic reviews and developing reusable learning objects for evidence-based practice. Current funded projects include maternal tobacco control initiatives, familial hypercholesterolemia management, and infant feeding guidelines with the Health Technology Assessment (HTA) program.

• Evidence Synthesis
• Meta-Analysis
• Systematic Reviews
• +۵ مورد دیگر

Johannes R. Kratz, MD, is an Associate Professor in the Department of Surgery at the University of California, San Francisco (UCSF), School of Medicine. He holds the Van Auken Endowed Chair in Thoracic Oncology and serves as Interim Chief of the Division of Thoracic Surgery. Kratz is also the Program Director of the Thoracic Surgery Residency Program, Director of Minimally Invasive and Robotic Thoracic Surgery, and Medical Director of Robotic Surgery at UCSF Health, highlighting his dual leadership in both academic and clinical domains. He earned his M.D. magna cum laude from Harvard Medical School, a Master of Arts in Philosophy from Stanford University, and completed his clinical training including a residency in General Surgery at Massachusetts General Hospital and a fellowship in Cardiothoracic Surgery at UCSF. His academic credentials are further strengthened by additional training in Diversity, Equity, and Inclusion from UCSF. Kratz’s research is centered on improving outcomes for patients with early-stage thoracic malignancies. His work focuses on developing and validating molecular prognostic assays, particularly a 14-gene signature for lung cancer, understanding tumor immunology, and advancing precision medicine through multi-omics and organoid models. He leads the Kratz Lab, which investigates the genetic and immunological drivers of lung, esophageal, and thymic cancers to discover novel therapeutic targets. His most recent publications, spanning 2023–2025, reveal a strong emphasis on neoadjuvant targeted therapies (especially osimertinib), immune microenvironment profiling using spatial and single-cell techniques, molecular risk stratification, and surgical outcomes research. His work bridges clinical trials, translational science, and surgical innovation, with a growing interest in the impact of the pandemic on surgical care and biomarker development for precision oncology. Scientific Awards and Honors: Van Auken Endowed Chair in Thoracic Oncology (2018) Michael DeBakey Research Scholarship, American Association for Thoracic Surgery (2019) Hellman Family Clinical-Translational Research Development Award (2019) UCSF Health Exceptional Physician Award (2017) Haile T. Debas Academy of Medical Educators Excellence in Teaching Award (2019, 2023) Cardiothoracic Surgery Faculty Teaching Award (2021) Soma Weiss Scholar, Harvard Medical School (2005) Howard Hughes Research Training Fellowship (2004) Kratz has been a Principal Investigator on multiple grants from the American Association of Thoracic Surgery, Bakar ImmunoX Foundation, Helen Diller Family Comprehensive Cancer Center, and UCSF. He actively mentors surgical trainees and contributes to medical education, reflected in his residency program leadership and teaching awards. He is also involved in clinical trials related to minimally invasive surgery and perioperative care. His lab, launched in 2018, is a hub for innovative research in early-stage lung cancer therapeutics.

• Thoracic Surgery
• Thoracic Oncology
• Lung Cancer
• +۱۳ مورد دیگر

Tracy Kuo Lin is a researcher at the University of California, San Francisco, affiliated with the Department of Health Policy and Health Economics. Her work focuses on health economics, public health, and policy analysis in conflict-affected and low-resource settings. University of Washington, BA in International Studies (2005) University College London, MS in Public Policy (2007) University of California, Davis, PhD in Political Science (2014) University of California, San Francisco, Postdoctoral Scholar in Health Policy and Health Economics (2016) London School of Economics and Political Science, Fellow in Health Economics (2017) Lin’s research explores cost-effectiveness of healthcare interventions, behavioral economics in health systems, and health impacts of conflict. She has authored 15+ peer-reviewed studies on topics like mobile health clinics, post-pandemic healthcare, and chronic disease prevention in schools. Her work has been recognized with grants such as the University of California, Davis Department Travel Grant (2014), the U.S. Department of Energy Network Science Idea Challenge (2015), and the Dean’s Recognition for Teaching Excellence at University of California, San Francisco (2020).

• Health Policy
• Health Economics
• Public Health
• +۳ مورد دیگر

Patricia Loftus is an Associate Professor in the Rhinology & Skull Base Surgery division at the University of California, San Francisco (UCSF) , specializing in nasal and sinus disorders. She obtained her medical degree from Jefferson Medical College and completed residency/fellowship training at Montefiore Medical Center and Emory University Hospital. Medical School: Jefferson Medical College of the Thomas Jefferson University Hospital Internship & Residency: Albert Einstein College of Medicine-Montefiore Medical Center Fellowship: Emory University Hospital - Rhinology & Endoscopic Skull Base Surgery Dr. Loftus focuses on Eustachian tube dysfunction in allergic contexts, fungal sinusitis , and hereditary hemorrhagic telangiectasia (HHT) . Her clinical expertise spans nasal and sinus surgery , endoscopic skull base surgery , and management of cerebrospinal fluid leaks . Recent research highlights include studies on in-office diagnostic techniques for eosinophilic rhinosinusitis, transcutaneous antifungal delivery for orbital fungal sinusitis, and long-term outcomes of posterior nasal nerve ablation for rhinitis. She has contributed to international consensus guidelines on allergic rhinitis. Professional memberships include the American Academy of Otolaryngology - Head and Neck Surgery , American Rhinologic Society , and North American Skull Base Society .

• Otolaryngology
• Rhinology
• Skull Base Surgery
• +۵ مورد دیگر

Eduard Bardají Rodríguez is a Professor in the Department of Chemistry at the University of Girona, where he has been active since 1992. He is affiliated with the Institute of Agro-Food Technology and leads the LIPPSO research group (Laboratory for Innovation in Organic Synthesis Processes and Products), recognized as a Consolidated Research Group by the Generalitat de Catalunya. His work bridges organic chemistry, biomedicine, and agro-food innovation through the design and application of bioactive peptides. Research Interests: His primary focus lies in the discovery and development of bioactive peptides with applications in antimicrobial, anticancer, analgesic, neuroprotective, and cardiovascular therapies. His work integrates synthetic organic chemistry with biological evaluation, aiming to translate basic findings into practical solutions in medicine and agriculture. The recent publication trends highlight a strong emphasis on peptide-based drug discovery, particularly targeting pain, neurodegeneration, and infectious diseases. His research extends into plant biotechnology (e.g., expressing antimicrobial peptides in rice) and combating citrus diseases (HLB), demonstrating a multidisciplinary approach spanning human health and sustainable agriculture. Scientific Awards and Recognition: Consolidated Research Group status for LIPPSO by the Generalitat de Catalunya Advising and Grants: He has led and participated in numerous competitive research projects, including MINECO, PLANT-KBBE (Trilateral Project), IAPP PEP2BRAIN, and H2020 PreHLB. He has established industrial collaborations with companies such as Medichem, Croda, and Menadione. He co-founded the spin-off AMPbiotech to commercialize antimicrobial technologies, reflecting a strong commitment to technology transfer and innovation. Laboratories and Teams: He leads the LIPPSO research group and maintains a strategic alliance with the CIDSAV group, fostering collaborative research in applied antimicrobial development.

• Organic Chemistry
• Bioactive Peptides
• Antimicrobial Development
• +۷ مورد دیگر

Mohamed S. Donia is an Associate Professor in the Department of Molecular Biology at Princeton University, where he leads the Donia Lab. His research focuses on small-molecule-mediated interactions within complex microbial communities and between microbes and their hosts, spanning human microbiome and marine symbiosis systems. B.Sc., Pharmacy, Suez Canal University, Egypt Ph.D., Medicinal Chemistry, University of Utah Postdoctoral Training, University of California, San Francisco Dr. Donia’s research lies at the intersection of microbiology, molecular biology, biochemistry, and computational biology. His lab investigates how small molecules mediate microbe-microbe and microbe-host interactions, particularly in the human gut and marine invertebrates. A key focus is on the role of the microbiome in drug metabolism and the discovery of novel bioactive compounds from uncultivable microbes using metagenomics and multi-omics approaches. The recent publications of the Donia Lab reveal a strong trend in microbiome-derived small molecule discovery, host-microbe interactions, and drug metabolism. The work spans human microbiome drug interactions , marine symbiotic chemistry , computational mining of biosynthetic gene clusters , and ecological modeling of microbial systems . These studies frequently appear in top-tier journals such as Cell , Science , and Nature , reflecting the high impact of the research. Scientific honors include: NIH Director’s New Innovator Award Kenneth Rainin Foundation Breakthrough Award Kenneth Rainin Foundation Innovation Award Pew Biomedical Scholar Dr. Donia actively mentors a diverse group of postdoctoral researchers, graduate students (including MD/PhD candidates), and undergraduates. His lab has received research funding from NIH and other agencies, enabling high-throughput, interdisciplinary studies. He is also a member of the Scientific Advisory Board for Deepbiome Therapeutics, indicating translational applications of his work. The Donia Lab operates as an interdisciplinary research team integrating experimental and computational methods. It maintains strong collaborations and develops tools like MetaBGC for metagenomic analysis of biosynthetic gene clusters. The lab culture emphasizes diversity, innovation, and scientific rigor, as reflected in its outreach and team composition.

• Microbiome Research
• Molecular Biology
• Microbial Interactions
• +۱۲ مورد دیگر

Mathias Munschauer leads the Department of Molecular Virology at Heidelberg University's Faculty of Medicine, within the Center for Infectious Diseases. His research group focuses on unraveling RNA regulatory mechanisms that govern viral infection outcomes, with emphasis on HCV, HBV, and Dengue virus. His research interests lie at the intersection of RNA biology and virology, particularly in understanding how viral RNA molecules interact with host cell components. The lab employs cutting-edge methodologies including RAP-MS and SHIFTR for RNA interactomics, integrated with functional genomics, single-cell transcriptomics, and AI-driven analysis of high-dimensional data. This systems-level approach enables the identification of host factors and regulatory pathways critical for viral replication and immune evasion. The recent publications highlight a strong trend toward spatially and temporally resolved analysis of RNA-protein interactions across diverse RNA viruses. There is a consistent focus on developing and applying innovative technologies to map host-virus interfaces, with applications in identifying antiviral targets and understanding infection mechanisms. The work spans molecular, cellular, and systems biology, with increasing integration of computational and machine learning approaches. Systems virology RNA-protein interactomics Host-pathogen interactions CRISPR screening Single-cell analysis Antiviral strategies Dr. Munschauer mentors a research team and contributes to the doctoral program in Infectious Diseases. His lab develops and shares novel reagents and methods, fostering collaborative science. While specific grants are not listed, the technological sophistication suggests substantial funding support. The lab operates within a vibrant research environment alongside other virology groups such as AG Bartenschlager and AG Ruggieri. The Munschauer Lab is part of a larger virology and infectious disease research ecosystem at Heidelberg University, collaborating across disciplines to advance understanding of viral pathogenesis. The team actively develops and applies innovative tools for RNA-centric discovery, positioning the group at the forefront of molecular virology.

• Molecular Virology
• RNA Biology
• Host-Pathogen Interactions
• +۷ مورد دیگر

Anna David is a Professor of Obstetrics and Maternal Fetal Medicine at University College London (UCL) . She serves as Director of the EGA Institute for Women’s Health and Deputy Director of Tommy's National Centre for Preterm Birth Research . David is also Visiting Professor at Katholieke Universiteit Leuven and holds the Professor Tan Seang Lin, Dr Grace Tan and OriginElle Fertility Distinguished Chair in Women’s Health since 2025. Education: BSc in Medical Science, University of St Andrews (1989) MB ChB, University of Manchester (1992) PhD in Fetal Gene Therapy, UCL (2005) Research Interests: David leads the Prenatal Therapy Group at UCL, focusing on developing prenatal treatments for severe fetal disorders. Her work spans fetal gene therapy , maternal VEGF gene therapy for growth restriction , fetal stem cell transplantation , and advanced imaging for fetal surgery . She also investigates preterm birth prediction/prevention and fetal growth restriction . Scientific Awards: Fellow of the Royal College of Obstetricians & Gynaecologists (2016) NIHR Senior Lectureship in Women’s Health (2008) Leadership & Collaboration: She is Lead for Women's Health Shadow Theme at the NIHR UCLH Biomedical Research Centre and Head of the Research Department of Maternal Fetal Medicine since 2016. David collaborates with institutions like KU Leuven and organizations such as Tommy's and Magnus Growth .

• Obstetrics
• Maternal-Fetal Medicine
• Prenatal Therapy
• +۳ مورد دیگر

Dr. Patrick A. Flume is a Professor in the Department of Medicine at the Medical University of South Carolina (MUSC) College of Medicine. He serves as the Powers-Huggins Endowed Chair for Cystic Fibrosis and focuses on patients with cystic fibrosis, bronchiectasis, and non-tuberculous mycobacteria (NTM) lung infections. Specializes in chronic infection management Expert in medication toxicities and treatment practices Leads multidisciplinary teams for pulmonary exacerbation research Develops quality improvement frameworks for respiratory care His work spans clinical trials (e.g., 2021 antibiotic duration study), guideline development (2018 ECFS revisions), and pathophysiological investigations (2025 neutrophil protease targeting). Research emphasizes disease heterogeneity, microbiome interactions, and equitable treatment access.

• Cystic Fibrosis
• Bronchiectasis
• Non-Tuberculous Mycobacteria (NTM) Infections
• +۴ مورد دیگر

Melanie Firestone is an Assistant Professor in the Division of Environmental Health Sciences at the University of Minnesota School of Public Health. Her academic journey includes a PhD in Environmental Health Sciences from the University of Minnesota, an MPH in Epidemiology from Columbia University, and a BS in Health & Exercise Science from Wake Forest University. Prior to joining the School of Public Health, she served as a CDC Epidemic Intelligence Service (EIS) Officer assigned to the Minnesota Department of Health. Dr. Firestone's research focuses at the intersection of infectious diseases and environmental health, with particular emphasis on improving public health surveillance systems to reduce enteric infections. Her work extensively examines the role of restaurants in foodborne illness transmission and prevention, as well as effective communication of food safety messages to the public. Her expertise spans public health surveillance, infectious disease epidemiology, foodborne disease investigation, food safety practices, and outbreak response. Analysis of her publication record reveals consistent research contributions in food safety, infectious disease epidemiology, and public health surveillance. Her work frequently involves collaborative investigations of foodborne outbreaks, SARS-CoV-2 transmission patterns, and zoonotic disease events. Recent publications demonstrate her focus on methodological improvements in outbreak detection and understanding transmission dynamics across various settings including restaurants, fitness centers, and households. Dr. Firestone is actively engaged with professional organizations including the Council for State and Territorial Epidemiologists, the International Association for Food Protection, and the Minnesota Environmental Health Association, demonstrating her commitment to advancing public health practice through professional collaboration and knowledge sharing.

• Public health surveillance
• Infectious disease
• Foodborne disease
• +۴ مورد دیگر